TY - JOUR
T1 - Breast Cancer Outcomes in Intersex Individuals in the National Cancer Database
AU - Chan, Kelley
AU - Cohen, Lauren
AU - Cotler, Joseph
AU - Carthcart-Rake, Elizabeth
AU - Berry, Adeline
AU - May Berner, Alison
AU - Cortina, Chandler S.
PY - 2026/6/20
Y1 - 2026/6/20
N2 - Up to 2% of the population is intersex, defined as individuals whose reproductive and/or sexual anatomy does not align with the historical definitions of male and female.1 Intersex characteristics often originate from chromosomal and inherited genetic variants (e.g., Klinefelter syndrome and Turner syndrome).1 Some may receive hormone replacement therapy,2,3,4 and while there are disparate outcomes in transgender/nonbinary/gender-diverse (TGD) patients with breast cancer,5 there are no cohorts examining intersex individuals. We aimed to explore patient demographics, tumor clinicopathologic features, treatment, and overall survival (OS) among patients with breast cancer and intersex characteristics in the National Cancer Database (NCDB).
AB - Up to 2% of the population is intersex, defined as individuals whose reproductive and/or sexual anatomy does not align with the historical definitions of male and female.1 Intersex characteristics often originate from chromosomal and inherited genetic variants (e.g., Klinefelter syndrome and Turner syndrome).1 Some may receive hormone replacement therapy,2,3,4 and while there are disparate outcomes in transgender/nonbinary/gender-diverse (TGD) patients with breast cancer,5 there are no cohorts examining intersex individuals. We aimed to explore patient demographics, tumor clinicopathologic features, treatment, and overall survival (OS) among patients with breast cancer and intersex characteristics in the National Cancer Database (NCDB).
KW - intersex
KW - breast cancer
KW - oncology
KW - healthcare
KW - LGBTQIA+
KW - Cancer
UR - https://www.scopus.com/pages/publications/105042381757
U2 - 10.1245/s10434-026-20027-2
DO - 10.1245/s10434-026-20027-2
M3 - Article
SN - 1068-9265
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
ER -